Frontiers in psychiatry · 2026
Baseline amyloid burden and global cognitive change during a home-based tDCS protocol in late-life depression: an exploratory single-arm study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Yiran, Park Jaesub, Park Jin Young, Kim Woo Jung
Аннотация
BACKGROUND: Late-life depression often co-occurs with cognitive difficulty, but whether amyloid burden is associated with mood and cognitive change during transcranial direct current stimulation (tDCS) in older adults is unknown.
METHODS: In this single-arm pre-post study, 41 older adults were enrolled; 3 withdrew before receiving the device, and 38 received home-based tDCS and completed baseline (V1), post-stimulation (V2), and follow-up (V3) assessments. Depression, insomnia, subjective cognition, MoCA, and a detailed cognitive battery were examined, and 31 change outcomes were regressed on Centiloid and 21 regional amyloid indicators with covariate adjustment.
RESULTS: No participant met the ≥50% GDS response criterion, whereas 60.5% showed a ≥2-point MoCA gain; the absent depression response reflects a floor effect expected from the low baseline severity rather than inefficacy. No association survived Benjamini-Hochberg correction across the complete exploratory family. In a biologically motivated Centiloid-only analysis, however, greater Centiloid burden was associated with smaller MoCA gain, and this association survived correction in both the full-analysis and per-protocol sets. Phonemic-fluency findings were less stable, and no comparable FDR-supported association was detected for depression, insomnia, or subjective cognition.
CONCLUSIONS: The findings do not support a broad amyloid-related cognitive pattern, but they identify a focused, hypothesis-generating Centiloid-MoCA association during the protocol. Because the study was single-arm, neither the observed changes nor the amyloid association can be attributed to stimulation itself. Controlled studies with prespecified outcomes are required.
METHODS: In this single-arm pre-post study, 41 older adults were enrolled; 3 withdrew before receiving the device, and 38 received home-based tDCS and completed baseline (V1), post-stimulation (V2), and follow-up (V3) assessments. Depression, insomnia, subjective cognition, MoCA, and a detailed cognitive battery were examined, and 31 change outcomes were regressed on Centiloid and 21 regional amyloid indicators with covariate adjustment.
RESULTS: No participant met the ≥50% GDS response criterion, whereas 60.5% showed a ≥2-point MoCA gain; the absent depression response reflects a floor effect expected from the low baseline severity rather than inefficacy. No association survived Benjamini-Hochberg correction across the complete exploratory family. In a biologically motivated Centiloid-only analysis, however, greater Centiloid burden was associated with smaller MoCA gain, and this association survived correction in both the full-analysis and per-protocol sets. Phonemic-fluency findings were less stable, and no comparable FDR-supported association was detected for depression, insomnia, or subjective cognition.
CONCLUSIONS: The findings do not support a broad amyloid-related cognitive pattern, but they identify a focused, hypothesis-generating Centiloid-MoCA association during the protocol. Because the study was single-arm, neither the observed changes nor the amyloid association can be attributed to stimulation itself. Controlled studies with prespecified outcomes are required.